The product license allows finished products to be marketed with claims relevant to liver, cardiovascular, and gut health, as well as blood glucose and stress.
The company plans to expand its carbon-neutral range of ingredients, offset emissions with sequestration projects, and engage in social impact projects.
The trade association for EPA and DHA omega-3s will have industry experts from TASA, Amway, dsm-firmenich, Aker BioMarine, and more on its board in 2024.